Noli C, Colombo S, Abramo F. Papular eosinophilic/mastocytic dermatitis (feline urticaria pigmentosa) in Devon Rex cats: a distinct disease entity or a histopathological reaction pattern? Vet Dermatol 2004; 15: 253–259.
Guagère E, Fontaine L. P-69 Efficacy of cyclosporin in the treatment of feline urticaria pigmentosa: two cases. Vet Dermatol 2004; 15: 63. DOI: 10.1111/j.1365-3164.2004.00414_69.x.
Vitale CB, Ihrke PJ, Olivry T. Feline urticaria pigmentosa in three related Sphynx cats. Vet Dermatol 1996; 7: 227–233.
Miller WH, Griffin CE, Campbell KL. Urticaria pigmentosa. In: Muller & Kirk’s small animal dermatology. 7th ed. St Louis, MO: Elsevier, 2013, p 612.
Muller GH, Kirk RW, Scott DW. Neoplastic diseases. In: Urticaria pigmentosa. 4th ed. Philadelphia: WB Saunders Company, 1989, p 899.
Azaña JM, Torrelo A, Matito A. Update on mastocytosis (part 1): pathophysiology, clinical features, and diagnosis. Actas Dermosifiliogr 2016; 107: 5–14.
Azaña JM, Torrelo A, Matito A. Update on mastocytosis (Part 2): categories, prognosis, and treatment. Actas Dermosifiliogr 2016; 107: 15–22.
Hartmann K, Escribano L, Grattan C. Cutaneous manifestations in patients with mastocytosis: consensus report of the European Competence Network on Mastocytosis; the American Academy of Allergy, Asthma & Immunology; and the European Academy of Allergology and Clinical Immunology. J Allergy Clin Immunol 2016; 137: 35–45.
Favrot C, Steffan J, Seewald W. Establishment of diagnostic criteria for feline nonflea-induced hypersensitivity dermatitis. Vet Dermatol 2011; 23: 45–e11.
Diesel A. Cutaneous hypersensitivity dermatoses in the feline patient: a review of allergic skin disease in cats. Vet Sci 2017; 4: 25–10.
Ben-Amitai D, Metzker A, Cohen HA. Pediatric cutaneous mastocytosis: a review of 180 patients. Isr Med Assoc J 2005; 7: 320–322.
Méni C, Bruneau J, Georgin-Lavialle S. Paediatric mastocytosis: a systematic review of 1747 cases. Br J Dermatol 2015; 172: 642–651.
Valent P, Akin C, Escribano L. Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment recommendations and response criteria. Eur J Clin Invest 2007; 37: 435–453.
Monnier J, Georgin-Lavialle S, Canioni D. Mast cell sarcoma: new cases and literature review. Oncotarget 2016; 7: 66299–66309.
Lamm CG, Stern AW, Smith AJ. Disseminated cutaneous mast cell tumors with epitheliotropism and systemic mastocytosis in a domestic cat. J Vet Diagn Invest 2009; 21: 710–715.
Hannaford R, Rogers M. Presentation of cutaneous mastocytosis in 173 children. Australas J Dermatol 2001; 42: 15–21.
Lee EH, Kim MR, Kang TW. Diffuse cutaneous mastocytosis with generalized bullae. Ann Dermatol 2010; 22: 77.
Lange M, Niedoszytko M, Nedoszytko B. Diffuse cutaneous mastocytosis: analysis of 10 cases and a brief review of the literature. J Eur Acad Dermatol Venereol 2012; 26: 1565–1571.
Morren M-A, Hoppé A, Renard M. Imatinib mesylate in the treatment of diffuse cutaneous mastocytosis. J Pediatr 2013; 162: 205–207.
Zuberbier T, Aberer W, Asero R. The EAACI/GA2LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update. Allergy 2014; 69: 868–887.
Yamamoto T, Katayama I, Nishioka K. Role of mast cell and stem cell factor in hyperpigmented mycosis fungoides. Blood 1997; 90: 1338–1340.
Kondo M, Igawa K, Munetsugu T. Increasing numbers of mast cells in skin lesions of hyperpigmented mycosis fungoides with large-cell transformation. Ann Dermatol 2016; 28: 115–112.
Brown CA, Chalmers SA. Diffuse cutaneous mastocytosis in a cat. Vet Pathol 1990; 27: 366–369.
Akin C, Valent P. Diagnostic criteria and classification of mastocytosis in 2014. Immunol Allergy Clin North Am 2014; 34: 207–218.
Colombo S, Scarampella F, Ordeix L. Dermatophytosis and papular eosinophilic/mastocytic dermatitis (urticaria pigmentosa-like dermatitis) in three Devon Rex cats. J Feline Med Surg 2012; 14: 498–502.
Lepri E, Ricci G, Leonardi L. Diagnostic and prognostic features of feline cutaneous mast cell tumours: a retrospective analysis of 40 cases. Vet Res Commun 2003; 27: 707–709.
Sabattini S, Bettini G. Prognostic value of histologic and immunohistochemical features in feline cutaneous mast cell tumors. Vet Pathol 2010; 47: 643–653.
Henry C, Herrera C. Mast cell tumors in cats. J Feline Med Surg 2012; 15: 41–47.
Noli C, Welle M, Scarampella F. Quantitative analysis of tryptase- and chymase-containing mast cells in eosinophilic conditions of cats. Vet Pathol 2003; 40: 219–221.
Rodríguez-Cariño C, Fondevila D, Segalés J. Expression of KIT receptor in feline cutaneous mast cell tumors. Vet Pathol 2009; 46: 878–883.
Isotani M, Yamada O, Lachowicz JL. Mutations in the fifth immunoglobulin-like domain of kit are common and potentially sensitive to imatinib mesylate in feline mast cell tumours. Br J Haematol 2009; 148: 144–153.
Isotani M, Tamura K, Yagihara H. Identification of a c-kit exon 8 internal tandem duplication in a feline mast cell tumor case and its favorable response to the tyrosine kinase inhibitor imatinib mesylate. Vet Immunol Immunopathol 2006; 114: 168–172.
Roosje PJ, Koeman JP, Thepen T. Mast cells and eosinophils in feline allergic dermatitis: a qualitative and quantitative analysis. J Comp Pathol 2004; 131: 61–69.
Schwartz LB, Irani AM. Serum tryptase and the laboratory diagnosis of systemic mastocytosis. Hematol Oncol Clin North Am 2000; 14: 641–657.
Bodemer C, Hermine O, Palmérini F. Pediatric mastocytosis is a clonal disease associated with D816V and other activating c-KIT mutations. J Invest Dermatol 2010; 130: 804–815.
Guaguère E, Bensignor E, Küry S. Clinical, histopathological and genetic data of ichthyosis in the golden retriever: a prospective study. J Small Anim Pract 2009; 50: 227–235.
Monk E, Shalita A, Siegel DM. Clinical applications of non-antimicrobial tetracyclines in dermatology. Pharmacol Res 2011; 63: 130–145.
Lortholary O, Chandesris MO, Livideanu CB. Masitinib for treatment of severely symptomatic indolent systemic mastocytosis: a randomised, placebo-controlled, phase 3 study. Lancet 2017; 389: 612–620.
Le M, Miedzybrodzki B, Olynych T. Natural history and treatment of cutaneous and systemic mastocytosis. Postgrad Med 2017; 129: 896–901.
Wiechers T, Rabenhorst A, Schick T. Large maculopapular cutaneous lesions are associated with favorable outcome in childhood-onset mastocytosis. J Allergy Clin Immunol 2015; 136: 1581–1590.e3.
